Blumen Sergiu C, Kesler Anat, Dabby Ron, Shalev Stavit, Khayat Morad, Almog Yechoshua, Zoldan Joseph, Benninger Felix, Drory Vivian E, Gurevich Michael, Sadeh Menachem, Brais Bernard, Braverman Itzhak
Department of Neurology, Hillel Yaffe Medical Center, Hadera, Israel.
Neuro-Ophthalmology Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Isr Med Assoc J. 2013 Dec;15(12):748-52.
Oculopharyngeal muscular dystrophy (OPMD) produced by the (GCG)13 expansion mutation in the PABPN1 gene is frequent among Uzbek Jews in Israel.
To describe the phenotypic and genotypic features in five Bulgarian Jewish patients, from different families, with autosomal dominant OPMD.
We performed clinical follow-up, electrodiagnostic tests and mutation detection. Blood samples were obtained after informed consent and DNA was extracted; measurement of GCG repeats in both PABPN1 alleles and sequencing of OPMD mutations were performed according to standard techniques.
We identified five patients (four females), aged 58 to 71 years, with bilateral ptosis, dysphagia, dysphonia (n = 3) and myopathic motor units by electromyography. In all patients we noticed proximal weakness of the upper limbs with winging scapulae in three of them. All cases shared the (GCG)13-(GCG)10 PABPN1 genotype.
OPMD among Bulgarian Jews is produced by a (GCG)13 expansion, identical to the mutation in Uzbek Jews and French Canadians. In addition to the classical neurological and neuro-ophthalmological features, early shoulder girdle weakness is common in Bulgarian Jewish patients; this is an unusual feature during the early stages of OPMD produced by the same mutation in other populations. We suggest that besides the disease-producing GCG expansion, additional ethnicity-related genetic factors may influence the OPMD phenotype. OPMD is a rare disease, and the identification of five affected families in the rather small Bulgarian Jewish community in Israel probably represents a new cluster; future haplotype studies may elucidate whether a founder effect occurred.
由PABPN1基因中(GCG)13重复序列扩增突变导致的眼咽型肌营养不良(OPMD)在以色列的乌兹别克犹太人中很常见。
描述来自不同家族的5例保加利亚犹太常染色体显性OPMD患者的表型和基因型特征。
我们进行了临床随访、电诊断测试和突变检测。在获得知情同意后采集血样并提取DNA;根据标准技术对PABPN1两个等位基因中的GCG重复序列进行测量,并对OPMD突变进行测序。
我们确定了5例患者(4名女性),年龄在58至71岁之间,有双侧上睑下垂、吞咽困难、发音障碍(3例),且肌电图显示为肌病性运动单位。在所有患者中,我们注意到上肢近端无力,其中3例伴有翼状肩胛。所有病例均具有(GCG)13-(GCG)10 PABPN1基因型。
保加利亚犹太人中的OPMD是由(GCG)13重复序列扩增导致的,与乌兹别克犹太人和法裔加拿大人中的突变相同。除了典型的神经和神经眼科特征外,早期肩胛带无力在保加利亚犹太患者中很常见;这在其他人群中由相同突变导致的OPMD早期阶段是不常见的特征。我们认为,除了致病的GCG重复序列扩增外,其他与种族相关的遗传因素可能会影响OPMD的表型。OPMD是一种罕见疾病,在以色列相当小的保加利亚犹太社区中发现5个受影响的家族可能代表一个新的聚集;未来的单倍型研究可能会阐明是否发生了奠基者效应。